EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
60.00
0.00 (0.00%)
At close: Apr 24, 2026
1.69% (1Y)
| Market Cap | 110.66M +14.4% |
| Revenue (ttm) | 9.37M +8.1% |
| Net Income | 2.38M +122.7% |
| EPS | 1.34 +122.5% |
| Shares Out | 1.78M |
| PE Ratio | 46.44 |
| Forward PE | n/a |
| Dividend | 1.83 (3.05%) |
| Ex-Dividend Date | n/a |
| Volume | 131 |
| Average Volume | 96 |
| Open | 60.00 |
| Previous Close | n/a |
| Day's Range | 60.00 - 60.00 |
| 52-Week Range | 57.50 - 65.50 |
| Beta | -0.03 |
| RSI | 46.18 |
| Earnings Date | Apr 28, 2026 |